BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24910369)

  • 61. Nomogram incorporating clinicopathological parameters to predict the survival of patients with mantle cell lymphoma.
    Zhu Y; Xu W; Zheng X; Zheng Z
    J Investig Med; 2019 Feb; 67(2):331-337. PubMed ID: 30258027
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine.
    Inamdar KV; Romaguera JE; Drakos E; Knoblock RJ; Garcia M; Leventaki V; Medeiros LJ; Rassidakis GZ
    Cancer; 2009 Oct; 115(20):4727-36. PubMed ID: 19708031
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tumor-associated neutrophils and macrophages in non-small cell lung cancer: no immediate impact on patient outcome.
    Carus A; Ladekarl M; Hager H; Pilegaard H; Nielsen PS; Donskov F
    Lung Cancer; 2013 Jul; 81(1):130-7. PubMed ID: 23540719
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma.
    Porrata LF; Ristow K; Habermann TM; Ozsan N; Dogan A; Macon W; Colgan JP; Witzig TE; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Nowakowski GS; Thompson C; Markovic SN
    Leuk Lymphoma; 2012 Nov; 53(11):2159-65. PubMed ID: 22551474
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis.
    Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X
    Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prognostic value of tumor-associated macrophages count in human non-muscle-invasive bladder cancer treated by BCG immunotherapy.
    Ajili F; Kourda N; Darouiche A; Chebil M; Boubaker S
    Ultrastruct Pathol; 2013 Feb; 37(1):56-61. PubMed ID: 23383616
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma.
    Hoster E; Dreyling M; Klapper W; Gisselbrecht C; van Hoof A; Kluin-Nelemans HC; Pfreundschuh M; Reiser M; Metzner B; Einsele H; Peter N; Jung W; Wörmann B; Ludwig WD; Dührsen U; Eimermacher H; Wandt H; Hasford J; Hiddemann W; Unterhalt M; ;
    Blood; 2008 Jan; 111(2):558-65. PubMed ID: 17962512
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prognostic relevance of clinical risk factors in mantle cell lymphoma.
    Hoster E
    Semin Hematol; 2011 Jul; 48(3):185-8. PubMed ID: 21782060
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Postoperative peripheral absolute blood lymphocyte-to-monocyte ratio predicts therapeutic outcome after pancreatic resection in patients with pancreatic adenocarcinoma.
    Fujiwara Y; Misawa T; Shiba H; Shirai Y; Iwase R; Haruki K; Furukawa K; Futagawa Y; Yanaga K
    Anticancer Res; 2014 Sep; 34(9):5163-8. PubMed ID: 25202109
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Negative prognostic impact of low absolute CD4
    Zhang XY; Xu J; Zhu HY; Wang Y; Wang L; Fan L; Wu YJ; Li JY; Xu W
    Cancer Sci; 2016 Oct; 107(10):1471-1476. PubMed ID: 27465799
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The absolute lymphocyte to monocyte ratio is associated with poor prognosis in classical Hodgkin lymphoma patients younger than 60 years of age.
    Koh YW; Jung SJ; Yoon DH; Suh C; Cha HJ; Go H; Kim JE; Kim CW; Huh J
    Hematol Oncol; 2015 Sep; 33(3):133-40. PubMed ID: 25224646
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic significance of CD163 expression and its correlation with cyclooxygenase-2 and vascular endothelial growth factor expression in cutaneous melanoma.
    Lee WJ; Lee MH; Kim HT; Won CH; Lee MW; Choi JH; Chang SE
    Melanoma Res; 2019 Oct; 29(5):501-509. PubMed ID: 30575644
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy.
    Holte H; Beiske K; Boyle M; Trøen G; Blaker YN; Myklebust J; Kvaløy S; Rosenwald A; Lingjaerde OC; Rimsza LM; Smeland EB; Scott DW; Kolstad A
    Br J Haematol; 2018 Oct; 183(2):225-234. PubMed ID: 30080252
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mantle cell lymphoma epidemiology: a population-based study in France.
    Leux C; Maynadié M; Troussard X; Cabrera Q; Herry A; Le Guyader-Peyrou S; Le Gouill S; Monnereau A
    Ann Hematol; 2014 Aug; 93(8):1327-33. PubMed ID: 24763513
    [TBL] [Abstract][Full Text] [Related]  

  • 75. miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator.
    Husby S; Ralfkiaer U; Garde C; Zandi R; Ek S; Kolstad A; Jerkeman M; Laurell A; Räty R; Pedersen LB; Pedersen A; Ehinger M; Sundström C; Karjalainen-Lindsberg ML; Delabie J; Clasen-Linde E; Brown P; Cowland JB; Workman CT; Geisler CH; Grønbæk K
    Blood; 2015 Apr; 125(17):2669-77. PubMed ID: 25736311
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mantle cell lymphoma: prognostic capacity of the Follicular Lymphoma International Prognostic Index.
    Møller MB; Pedersen NT; Christensen BE
    Br J Haematol; 2006 Apr; 133(1):43-9. PubMed ID: 16512827
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Post-treatment (not interim) positron emission tomography-computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with R-HyperCVAD.
    Mato AR; Svoboda J; Feldman T; Zielonka T; Agress H; Panush D; Miller M; Toth P; Lizotte PM; Nasta S; Goldberg S; Chong E; Schuster S; Pecora AL; Goy A
    Cancer; 2012 Jul; 118(14):3565-70. PubMed ID: 22180256
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma.
    Kato A; Imai Y; Aoki K; Tabata S; Matsushita A; Hashimoto H; Takahashi T; Ishikawa T
    Ann Hematol; 2014 Jul; 93(7):1185-91. PubMed ID: 24526138
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma.
    Jones K; Vari F; Keane C; Crooks P; Nourse JP; Seymour LA; Gottlieb D; Ritchie D; Gill D; Gandhi MK
    Clin Cancer Res; 2013 Feb; 19(3):731-42. PubMed ID: 23224400
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Abnormal serum free light chain ratio predicts poor overall survival in mantle cell lymphoma.
    Furtado M; Shah N; Levoguer A; Harding S; Rule S
    Br J Haematol; 2013 Jan; 160(1):63-9. PubMed ID: 23094783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.